Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Documenti analoghi

• Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers
  di: Gu N, et al.
  Pubblicazione: (2014-10-01)
• Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
  di: Rhee, Su-jin, et al.
  Pubblicazione: (2016)
• Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
  di: Lim, Kyoung Soo, et al.
  Pubblicazione: (2009)
• Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
  di: Yoo, Hyounggyoon, et al.
  Pubblicazione: (2020)
• Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
  di: Hwang, Inyoung, et al.
  Pubblicazione: (2020)